The Sevoflurane study, understanding the effects of Sevoflurane to improve safety and outcome of cardiac surgery - Sevo-study
- Conditions
- myocardial ischemia reperfusion injury during cardiac surgeryMedDRA version: 9.1Level: LLTClassification code 10017501Term: Functional disturbances following cardiac surgery
- Registration Number
- EUCTR2009-012372-27-NL
- Lead Sponsor
- MC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients without heart failure (EF < 35%) accepted for mitral valve surgery via sternotomy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Acceptation for minimal invasive mitral valve surgery, inability to sign informed consent, less than 18 years old, emergency operations
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Understanding the effects of Sevoflurane on ischemia reperfusion injury of the myocardium to improve safety and outcome of cardiac surgery;Secondary Objective: ;Primary end point(s): Inflammatory biomarkers
- Secondary Outcome Measures
Name Time Method